Related Experiment Video
Updated: Jun 30, 2025
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022
Ephrin B1 Regulates Inflammatory Pathways in Retinal Müller Cells
Li Liu1, Youde Jiang1, Mohamed Al-Shabrawey2,3
1Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Abstract:
The role of inflammation has been accepted as a factor in the complications of diabetic retinopathy. Discovery of the upstream regulation of these inflammatory factors has remained a challenge. In this study, we explored the actions of ephrin B1 in retinal Müller cells and their actions on inflammatory proteins. We used diabetic human and mouse samples, as well as Müller cells in culture to measure ephrin B1 in Müller cells. We then generated Müller cell specific ephrin B1 knockout mice. We measure levels of key inflammatory proteins, including high mobility group box 1 (HMGB1) and NOD-like receptor protein 3 (NLRP3) pathway proteins in retinal lysates from the ephrin B1 floxed and ephrin B1 Müller cell specific knockout mice. Data show that ephrin B1 is significantly increased in the retina of diabetic humans and mice, as well as in Müller cells grown in high glucose. Elimination of ephrin B1 in mouse Müller cells led to a significant decline in all inflammatory proteins studied. In conclusion, a reduction in ephrin B1 in the diabetic retina may offer a new therapeutic modality for diabetic retinopathy.
Insights
Ephrin B1 in retinal Müller cells drives inflammation in diabetic retinopathy. Reducing ephrin B1 significantly decreased key inflammatory proteins, suggesting a potential therapeutic target for diabetic eye disease.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Medicine
Background:
- Inflammation is a known factor in diabetic retinopathy complications.
- Upstream regulators of inflammatory factors in diabetic retinopathy remain poorly understood.
Purpose of the Study:
- To investigate the role of ephrin B1 in retinal Müller cells.
- To determine the effect of ephrin B1 on inflammatory protein expression in the context of diabetes.
Main Methods:
- Analysis of ephrin B1 levels in human and mouse diabetic retinas and cultured Müller cells.
- Generation of Müller cell specific ephrin B1 knockout mice.
- Quantification of inflammatory proteins (HMGB1, NLRP3 pathway) in retinal lysates.
Main Results:
- Ephrin B1 levels were significantly elevated in diabetic retinas and high-glucose cultured Müller cells.
- Elimination of ephrin B1 in Müller cells resulted in a significant reduction of studied inflammatory proteins.
- Data indicate a direct link between ephrin B1 and inflammatory pathways in diabetic retinopathy.
Conclusions:
- Ephrin B1 is upregulated in the diabetic retina and influences key inflammatory pathways.
- Targeting ephrin B1 in Müller cells may represent a novel therapeutic strategy for diabetic retinopathy.
- Further research into ephrin B1 inhibition could lead to new treatments for diabetic eye disease.
Related Concept Videos
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...